Anlotinib Combined With Chemotherapy for the Treatment of HER2 Negative Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: HER2-negative Breast Cancer
Sponsor: The First Affiliated Hospital with Nanjing Medical University